27th Annual EuroMeeting

A panel of respected leaders from academia, industry, health agencies, patient advocacy, and the payer community will share perspectives on the dichotomy between evolving diseases, well-known conditions, and neglected and rare diseases, contrasted with the challenges that exist in understanding the physiology of these conditions and developing therapies to treat them. The challenges include topics such as the efficiency of R&D, access to health care, ethics and transparency issues related to the clinical trials, and the increasing challenges related to investments required to bring safe, effective, economically-viable, and accessible products to patients worldwide. All stakeholders see the challenges, but each from a different perspectives: health authorities in terms of the public health preservation, industry in terms of ROI, academics in terms of generating new knowledge, payers in terms of risk management, patients in terms of managing their disease. During this provocative and stimulating discussion, the panellists will work to converge on a shared vision and call to action.